Dr. Leslie Citrome: Addressing tardive dyskinesia

In this edition of the MDedge Psychast, Lorenzo Norris, MD, welcomes Leslie Citrome, MD, of New York Medical College in Valhalla, NY, for a conversation on the challenges of TD.

Sanjay Gupta, MD, of the University of Buffalo, spoke in an MDedge video earlier this year on the importance of using the Abnormal Involuntary Movement Scale to screen for TD and treating the disorder with vesicular monoamine transporter-2 inhibitors.

In the episode, Dr. Citrome notes that despite recent advances in pharmacological options, clinicians can be challenged by TD.

In this edition of the MDedge Psychast, Lorenzo Norris, MD, welcomes Leslie Citrome, MD, of New York Medical College in Valhalla, NY, for a conversation on the challenges of TD.

Sanjay Gupta, MD, of the University of Buffalo, spoke in an MDedge video earlier this year on the importance of using the Abnormal Involuntary Movement Scale to screen for TD and treating the disorder with vesicular monoamine transporter-2 inhibitors.

In the episode, Dr. Citrome notes that despite recent advances in pharmacological options, clinicians can be challenged by TD.

In this edition of the MDedge Psychast, Lorenzo Norris, MD, welcomes Leslie Citrome, MD, of New York Medical College in Valhalla, NY, for a conversation on the challenges of TD.

Sanjay Gupta, MD, of the University of Buffalo, spoke in an MDedge video earlier this year on the importance of using the Abnormal Involuntary Movement Scale to screen for TD and treating the disorder with vesicular monoamine transporter-2 inhibitors.

In the episode, Dr. Citrome notes that despite recent advances in pharmacological options, clinicians can be challenged by TD.